Monsanto Announces Global Genome-Editing Licensing Agreement With Broad Institute For Newly-Characterized CRISPR System

Monsanto Company announced that it has reached a new global licensing agreement with the Broad Institute of MIT and Harvard for the use of the novel CRISPR-Cpf1 genome-editing technology in agriculture. The CRISPR-Cpf1 system represents an exciting advance...
Read More

MONSANTO ANNOUNCES GLOBAL LICENSING AGREEMENT WITH BROAD INSTITUTE ON KEY GENOME-EDITING APPLICATION

Monsanto Company announced that it has reached a global licensing agreement for the use of the CRISPR-Cas genome-editing technology in agriculture with the Broad Institute of MIT and Harvard. The Broad Institute is a world leader in the development and...
Read More

MONSANTO DID NOT GHOSTWRITE THE WILLIAMS ET AL (2000) GLYPHOSATE PAPER

(Originally published in Beyond the Rows) Recently, in the context of personal injury litigation filed against Monsanto, plaintiffs’ attorneys have cherry picked a single email – out of more than 10 million pages of documents produced – to allege...
Read More

MONSANTO GREENHOUSES IN PUERTO RICO: RAISING THE BAR IN INNOVATION, TECHNOLOGY, AND AGRICULTURAL SUSTAINABILITY AT A GLOBAL SCALE

The southern area of the island of Puerto Rico is the center stage for one of Monsanto’s most ambitious projects in agricultural technology in the world: the establishment of smart greenhouses for sustainable cotton and soy conversion projects. Technological...
Read More